However, the significant reverse of the KCa1.1 inhibition-induced down-regulation of CEBPB and CYP3A4 by KCa1.1 inhibition was not observed following the treatment with JNK and ERK inhibitors in cancer spheroid models (Figure 12). The gene discussed is MAPK8; the disease is cancer.